IPSS-M Guide: High-level genomic risk stratification. Combines clinical parameters with NGS data. Note: Full IPSS-M calculation requires specialized algorithmic software; this tool highlights the prognostic impact of key genes.
Molecular Risk Impact
Favorable molecular profile (no adverse drivers identified).
Verified
Last Review: 2026-07-17
Bernard E et al. • NEJM Evidence. 2022;1(7). n=2,831 patients.
View SourceLast Comprehensive Review: 2026-07-17
Scanning Medical Journals
No new significant updates or guidelines matching this topic were found today. We will check again soon.
